Function and clinical use of interleukin-12

Current Opinion in Hematology

Volumn 4, Issue 1, 1997, Pages 59-66

  Trinchieri, Giorgio ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12;

ALLERGIC REACTION; ANTIGEN PRESENTATION; CELL FUNCTION; CELL MATURATION; COVALENT BOND; HELPER CELL; HUMAN; HUMAN CELL; KILLER CELL; NEGATIVE FEEDBACK; PHAGOCYTOSIS; PRIORITY JOURNAL; REVIEW; VACCINATION; VIRUS TRANSFORMATION;

EID: 0031057296     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199704010-00010     Document Type: Review

References (78)

1. Trinchieri G: Interleukin 12: a cytokine produced by antigen-presenting cells with Immunoregulatory functions in the generation of T helper cells type 1 and cytotoxic lymphocytes. Blood 1994, 84:4008-4027.
2. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste-Amezaga M, Chan SH, Kobayashi M, Young D, Nickbarg E, Chizzonite R, Wolf SF, Trinchieri G: Production of natural killer cell stimulatory factor (NKSF/IL-12) by peripheral blood mononuclear cells. J Exp Med 1992, 176:1387-1398.
3. + T cells. J Immunol 1995, 154:5071-5079. First demonstration that dendritic cells, when presenting antigen to T cells, produce interleukin-12 and, in the absence of interleukin-4, direct the development of Th1 cells.
4. Kang K, Kubin M, Cooper KD, Lessin SR, Trinchieri G, Rook AH: IL-12 synthesis by human Langerhans cells. J Immunol 1996, 156:1402-1407.
5. Benjamin D, Sharma V, Kubin M, Klein JL, Sartori A, Holliday J, Trinchieri G: IL-12 expression in AIDS-related lymphoma B cell lines. J Immunol 1996, 156:1626-1637.
6. Coutelier JP, Van Broeck J, Wolf SF: Interleukin-12 gene expression after viral infection in the mouse. J Virol 1995, 69:1955-1958.
7. Cleveland MG, Gorham JD, Murphy TL, Tuomanen E, Murphy KM: Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infect Immun 1996, 64:1906-1912. Identification of the involvement of CD14 in the production of interleukin-12 in response to products of both gram-positive and gram-negative bacteria.
8. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM: CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci U S A 1996, 93:2879-2883. Characterization of CpG motif containing bacterial DNA as another mechanism of interleukin-12 induction.
9. Heufler C, Koch F, Stanzl U, Topar G, Wysocka M, Trinchieri G, Enk A, Steinman RM, Romani N, Schuler G: Interleukin-12 is produced by dendritic cells and mediates Th1 development as well as interferon-γ production by Th1 cells. Eur J Immunol 1996, 26:659-668.
10. Scheicher C, Mehlig M, Dienes HP, Reske K: Uptake of microparticle-absorbed protein antigen by bone marrow-derived dendritic cells results in up-regulation of IL-1-α and IL-12 p40/p35 and triggers prolonged, efficient antigen presentation. Eur J Immunol 1995, 25:1566-1572.
11. Cella M, Scheidegger D, Plamer-Lehmann K, Lane P, Lanzavecchia A, Alber G: Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996, 184:747-752.
12. Koch F, Stanzl U, Jennewein P, Janke K, Heufler C, Kämpgen E, Romani N, Schuler G: High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10. J Exp Med 1996, 184:741-746. A detailed analysis of the mechanism of induction and suppression of interleukin-12 production in dendritic cells.
13. Shu U, Kiniwa M, Wu CY, Maliszewski C, Vezzio N, Hakimi J, Gately M, Delepesse G: Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 1995, 25:1125-1128. The first description of interleukin-12 induction in monocytes by CD40-CD40 ligand interaction.
14. Kennedy MK, Picha KS, Fanslow WC, Grabstein KH, Alderson MR, Clifford KN, Chin WA, Mohler KM: CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur J Immunol 1996, 26:370-378.
15. Magram J, Connaughton SE, Warrier RR, Carvajal DM, Wu CY, Ferrante J, Stewart C, Sarmiento U, Faherty DA, Gately MK: IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 1996, 4:471-481. Description of interleukin-12 p40-deficient mice and of their impaired ability to produce interferon gamma in response to endotoxin, to generate effective Th1 responses, and to mediate delayed-type hypersensitivity responses.
16. Hunter CA, Chizzonite R, Remington JS: IL-1β is required for IL-12 to Induce production of IFN-γ by NK cells: a role for IL-1β in the T cell-independent mechanism of resistance against intracellular pathogens. J Immunol 1995, 155:4347-4354.
17. Kubin M, Chow JM, Trinchieri G: Differential regulation of interleukin-12 (IL-12), tumor necrosis factor-α, and IL-1β production in human myeloid leukemia cell lines and peripheral blood mononuclear cells. Blood 1994, 83:1847-1855.
18. Flesch IEA, Hess JH, Huang S, Aguet M, Rothe J, Bluethmann H, Kaufmann SHE: Early interleukin 12 production by macrophages in response to mycobactarial infection depends on interferon γ and tumor necrosis factor α J Exp Med 1995, 181:1615-1621.
19. Ma X, Chow JM, Gri G, Carra G, Gerosa F, Wolf SF, Dzialo R, Trinchieri G: The interleukin-12 p40 gene promoter is primed by interferon-γ in monocytic cells. J Exp Med 1996, 183:147-157. Demonstration that interferon gamma and lipopolysaccharide regulate both the p35 and p40 genes at the transcriptional level and identification of a functional ets site in the human interleukin-12 p40 promoter.
20. Murphy TL, Cleveland MG, Kulesza P, Magram J, Murphy KM: Regulation of interleukin 12 p40 expression through an NF-κB half-site. Mol Cell Biol 1995, 15:5258-5267. Characterization of some of the mechanisms of transcriptional regulation of the murine interleukin-12 p40 promoter.
21. D'Andrea A, Aste-Amezaga M, Valiante NM, Ma X, Kubin M, Trinchieri G: Interleukin-10 inhibits human lymphocyte IFN-γ production by suppressing natural killer cell stimulatory factor/interleukln-12 synthesis in accessory cells. J Exp Med 1993, 178:1041-1048.
22. + T cells and accompanied by overproduction of IL-12, IFN-γ and TNF-α J Immunol 1996, 157:798-805. Demonstration of the importance of endogenous interleukin-10 in vivo in down-regulating interleukin-12 production during infections and preventing toxicity due to overproduction of proinflammatory cytokines.
23. Gerosa F, Paganin C, Peritt D, Paiola F, Scupoli MT, Aste-Amezaga M, Frank I, Trinchieri G: Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-γ and interleukin-10. J Exp Med 1996, 183:2559-2569. Analysis of the activity of interleukin-12 and interleukin-4 and their combination in determining priming for cytokine production in clonal T cells.
24. Meynaard L, Hovenkamp E, Otto SA, Miedema F: IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. J Immunol 1996, 156:2776-2782.
25. Windhagen A, Anderson DE, Carrizosa A, Williams RE, Hafler DA: IL-12 induces human T cells secreting IL-10 with IFN-γ. J Immunol 1996, 157:1127-1131.
26. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G: Stimulatory and inhibitory effects of IL-4 and IL-13 on production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and TNF-α production. J Exp Med 1995, 181:537-546.
27. Stüber E, Strober W, Neurath M: Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 1996, 183:693-698. Demonstration of the relevance of the T-cell-dependent pathway (CD40-CD40 ligand interaction) in vivo for production of interleukin-12 in response to antigens.
28. Manetti R, Gerosa F, Giudizi MG, Biagiotti R, Parronchi P, Piccinni M, Sampognaro S, Maggi E, Romagnani S, Trinchieri G: Interleukin-12 Induces stable priming for interferon-γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones. J Exp Med 1994, 179:1273-1283.
29. Gazzinelli RT, Wysocka M, Hayashi S, Deukers EY, Hieny S, Caspar P, Trinchieri G, Sher A: Parasite induced IL-12 stimulates early interferon-γ synthesis and resistance during acute infection with Toxoplasma gondii. J Immunol 1994, 153:2533-2543.
30. Murphy EE, Terres G, Macatonia SE, Hsieh C, Mattson J, Lanier L, Wysocka M, Trinchieri G, Murphy K, O'Garra A: B7 and IL-12 cooperate for proliferation and IFN-γ production by mouse T helper clones that are unresponsive to B7 costimulation. J Exp Med 1994, 180:223-231.
31. Maruo S, Toyo-ka K, Oh-ora M, Tai X, Iwata H, Takenaka H, Yamada S, Ono S, Hamaoka T, Kobayashi M, Wysocka M, Trinchieri G, Fujiwara H: IL-12 produced by antigen-presenting cells induces IL-2-independent proliferation of T helper cell clones. J Immunol 1996, 156:1748-1755. Analysis of differentiated Th1 clones that have lost the ability to produce interleukin-12 and are dependent on interleukin-12 produced by antigen-presenting cells for antigen-induced proliferation.
32. H1 cells. Science 1995, 269:245-247. Demonstration of the downregulation of interferon gamma receptor β chain (interferon gamma R2) in Th1 cells.
33. Szabo SJ, Jacobson NG, Dighe AS, Gubler U, Murphy KM: Developmental commitment to the Th2 lineage by extinction of IL-12 signaling. Immunity 1995, 2:665-675. Analysis of the downregulation of interleukin-12 responsiveness in Th2 cells of BALB/c mice.
34. Orange JS, Biron CA: An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense: studies of natural killer and T cell responses in contrasting viral infections. J Immunol 1996, 156:1138-1142. Demonstration and detailed analysis of interleukin-12-dependent and interleukin-12-independent mechanisms of interferon gamma production in viral infections.
35. Orange JS, Salazar-Mather TP, Opal SM, Spencer RL, Miller AH, McEwen BS, Biron CA: Mechanism of interleukin-12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids. J Exp Med 1995, 181:901-914.
36. Ozmen L, Aguet M, Trinchieri G, Garotta G: The in vivo antiviral activity of IL-12 is mediated by IFN-γ. J Virol 1995, 69:8147-8150.
37. Bi Z, Quandt P, Komatsu T, Barna M, Reiss CS: IL-12 promotes enhanced recovery from vesicular stomatitis virus infection of the central nervous system. J Immunol 1995, 155:5684-5689.
38. Matsuo R, Kobayashi M, Herndon DN, Pollard RB, Suzuki F: Interleukin-12 protects thermally injured mice from herpes simplex virus type 1 infection. J Leukoc Biol 1996, 59:623-630.
39. Fantuzzi L, Gessani S, Borghi P, Varano B, Conti L, Puddu P, Belardelli F: Induction of interleukin-12 (IL-12) by recombinant glycoprotein gp120 of human immunodeficiency virus type 1 in human monocytes/macrophages: requirement of gamma-interferon for IL-12 secretion. J Virol 1996, 70:4121-4124.
40. Denis M, Ghadirian E: Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects. AIDS Res Hum Retroviruses 1994, 10:1619-1627.
41. Chougnet C, Wynn TA, Clerici M, Landay AL, Kessler HA, Rusnak J, Melcher GP, Sher A, Shearer GM: Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J Infect Dis 1996, 174:46-53. First detailed analysis of accumulation of p40 and p35 interleukin-12 mRNA in monocytes from HIV-infected patients.
42. Daftarian MP, Diaz-Mitoma F, Creery WD, Cameron W, Kumar A: Dysregulated production of interleukin-10 (IL-10) and IL-12 by peripheral blood lymphocytes from human immunodeficiency virus-infected individuals is associated with altered proliferative responses to recall antigens. Clin Diagn Lab Immunol 1995, 2:712-718.
43. Karp CL, Wysocka M, Wahl LM, Aheam JM, Cuomo PJ, Sherry B, Trinchieri G, Griffin DE: Mechanism of suppression of cell-mediated immunity by measles virus. Science 1996, 273:228-231. Demonstration that measles virus infection of monocytes in vitro selectively inhibits interleukin-12 production, while minimally affecting other cytokines.
44. Tang YW, Graham BS: Interleukin-12 treatment during immunization elicits a T helper cell type 1-like Immune response in mice challenged with respiratory syncytial virus and Improves vaccine immunogenicity. J Infect Dis 1995, 172:734-738.
45. Tembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L: Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 1995, 181:817-821.
46. Germann T, Szeliga J, Hess H, Storkel S, Podlaski FJ, Gately MK, Schmitt E, Rüde E: Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc Natl Acad Sci U S A 1995, 92:4823-4827.
47. Waldburger KE, Hastings RC, Goldman SJ, Leonard JP: Adoptive transfer of experimental allergic encephalomyelitis after in vitro treatment with recombinant murine interleukin-12: preferential expansion of interferon-gamma-producing cells and increased expression of macrophage-associated inducible nitric oxide synthase as immunomodulatory mechanisms. Am J Pathol 1996, 148:375-382.
48. Segal BM, Shevach EM: IL-12 unmasks latent autoimmune disease in resistant mice. J Exp Med 1996, 184:771-775.
49. Neurath MF, Fuss I, Kelsall BL, Stüber E, Strober W: Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 1995, 182:1281-1290. Demonstration that interleukin-12 is necessary for both induction and maintenance of hapten-induced colitis in mice.
50. Huang FP, Feng GJ, Lindop G, Stott DI, Liew FY: The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL:MP-lpr:lpr mice. J Exp Med 1996, 183:1447-1459. Demonstration that in MRL/lpr mice, interleukin-12 is overproduced and contributes to the autoimmune disease.
51. Windhagen A, Newcombe J, Dangond F, Strand C, Woodroofe MN, Cuzner ML, Hafler DA: Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 1995, 182:1985-1996. Identification of interleukin-12 and molecules (67) acting in synergy with interleukin-12 in multiple sclerosis plaques, which suggests a pathogenic role of interleukin-12 in this disease.
52. Bucht A, Larsson P, Weisbrot L, Thome C, Pisa P, Smedegard G, Keystone EC, Gronberg A: Expression of interferon-gamma (IFN-γ), IL-10, IL-12 and transforming growth factor-beta (TGF-beta) mRNA in synovial fluid cells from patients in the early and late phases of rheumatoid arthritis (RA). Clin Exp Immunol 1996, 103:357-367.
53. Moller DR, Forman JD, Liu MC, Noble PW, Greenlee BM, Vyas P, Holden D, Forrester JM, Lazarus A, Wysocka M, Trinchieri G, Karp C: Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 1996, 156:4952-4960. Overproduction of interleukin-12 by lung alveolar macrophages may have a pathogenetic role in sarcoidosis.
54. Bhardwaj N, Seder RA, Reddy A, Feldman MV: IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro. J Clin Invest 1996, 98:1-8.
55. Gavett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD, Wills-Karp M: Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 1995, 182:1527-1536. Detailed analysis of the ability of interleukin-12 to suppress antigen-inducing eosinophilia and airway hyperresponsiveness in a mouse model of asthma.
56. Brunda MJ: Role of IL-12 as an antitumor agent: current status and future directions. Res Immunol 1995, 146:622-627.
57. Voest EE, Kenyon BM, O'Reilly MS, Truitt G, D'Amato RJ, Folkman J: Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 1995, 87:581-586.
58. Sgadari C, Angiolillo AL, Tolsato G: Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10. Blood 1996, 87:3877-3882.
59. Fallarino F, Uyttenhovec C, Boon T, Gajewski TF: Endogenous IL-12 is necessary for rejection of P815 tumor variants in vivo. J Immunol 1996, 156:1095-1100. Evidence that interleukin-12 may have a role in the immune surveillance of immunogenic tumors.
60. Zitvogel L, Tahara H, Cai Q, Storkus WJ, Muller G, Wolf SF, Gately M, Robbins PD, Lotze MT: Construction and characterization of retroviral vectors expressing biologically active human interleukin-12. Hum Gene Ther 1994, 5:1493-1506.
61. Meko JB, Yim JH, Tsung K, Norton JA: High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12. Cancer Res 1995, 55:4765-4770.
62. Zitvogel L, Tahara H, Robbins PD, Storkus WJ, Clarke MR, Nalesnik MA, Lotze MT: Cancer immunotherapy of established tumors with IL-12: effective delivery by genetically engineered fibroblasts. J Immunol 1995, 155:1393-1403.
63. Martinotti A, Stoppacciaro A, Vagliani M, Melani C, Spreafico F, Wysocka M, Parmiani G, Trinchieri G, Colombo M: CD4 T cells inhibit in vivo CD8-mediated immune response against a murine colon carcinoma transduced with IL-12 genes. Eur J Immunol 1995, 25:137-146.
64. Tahara H, Zitvogel L, Storkus WJ, Zeh HJ III, McKinney TG, Schreiber RD, Gubler U, Robbins PD, Lotze MT: Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J Immunol 1995, 154:6466-6474.
65. Wigginton JM, Kuhns DB, Back TC, Brunda MJ, Wiltrout RH, Cox GW: Interleukin 12 primes macrophages for nitric oxide production in vivo and restores depressed nitric oxide production by macrophages from tumor-bearing mice: implications for the antitumor activity of interleukin 12 and/or interleukin 2. Cancer Res 1996, 56:1131-1136.
66. Vagliani M, Rodolfo M, Cavallo F, Parenza M, Melani C, Parmiani G, Forni G, Colombo MP: Interleukin 12 potentiates the curative effect of a vaccine based on interleukin 2-transduced tumor cells. Cancer Res 1996, 56:467-470.
67. Coughlin CM, Wysocka M, Kurzawa HL, Lee WMF, Trinchieri G, Eck SL: B7-1 and IL-12 synergistically Induce effective antitumor immunity. Cancer Res 1995, 55:4980-4987. First demonstration of the in vivo synergy between interleukin-12 and B7 in inducing tumor rejection and antitumor immune resistance.
68. Zitvogel L, Robbins PD, Storkus WJ: Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors. Eur J Immunol 1996, 26:1335-1341.
69. Cohen J: IL-12 deaths: explanation and a puzzle. Science 1995, 270:908.
70. Jenks S: After Initial setback, IL-12 regaining popularity. J Natl Cancer Inst 996, 88:576-577.
71. Car BD, Eng VM, Schnyder B, LeHir M, Shakhov AN, Woerly G, Huang S, Aguet M, Anderson TD, Tyffel B: Role of interferon-γ in IL-12-induced pathology in mice. Am J Pathol 1995, 147:1693-1707. Detailed analysis of the toxicity of interleukin-12 in mice and its dependence and independence from interferon gamma.
72. Jacobsen SEW: IL-12, a direct stimulator and indirect inhibitor of hematopoiesis. Res Immunol 1995, 146:506-514.
73. Bellone G, Trinchieri G: Dual stimulatory and inhibitory effect of NK cell stimulatory factor/IL-12 on human hematopoiesis. J Immunol 1994, 153:930-937.
74. Eng VM, Car BD, Schnyder B, Lorenz M, Lugli S, Aguet M, Anderson TD, Ryffel B, Quesniaux VFJ: The stimulatory effects of interleukin (IL)-12 on hematopoiesis are antagonized by IL-12-induced interferon gamma in vivo. J Exp Med 1995, 181:1893-1898.
75. Wynn TA, Cheever AW, Jankovic D, Poindexter RW, Caspar P, Lewis FA, Sher A: An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 1995, 376:594-596.
76. Bliss J, Van Cleave V, Murray K, Wiencis A, Ketchum M, Maylor R, Haire T, Resmini C, Abbas AK, Wolf SF: IL-12, as an adjuvant, promotes a T helper 1 cell, but does not suppress a T helper 2 cell recall response. J Immunol 1996, 156:887-894.
77. Noguchi Y, Richards EC, Chen Y, Old LJ: Influence of IL-12 on p53 peptide vaccination against established Meth A sarcoma. Proc Natl Acad Sci U S A 1995, 92:2219-2223.
78. Rao JB, Chamberlain RS, Bronte V, Carroll MW, Irvine KR, Moss B, Rosenberg SA, Restifo NP: IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression. J Immunol 1996, 156:3357-3365.